acquired
Stage
About
PhaseRx is a biotechnology company developing polymer-based RNA delivery technologies (including SMARTT Polymer Technology) to enable systemic delivery of RNAi/mRNA therapeutics for orphan and inherited liver enzyme deficiency diseases.
Explore PhaseRx, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.